Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Petros Pharmaceuticals (PTPI)
NASDAQ:PTPI
Holding PTPI?
Track your performance easily
Petros Pharmaceuticals (PTPI) Ownership Overview
0.76% Mutual Funds
0.71% Other Institutional Investors
0.32% ETFs
98.21% Public Companies and Individual Investors
The ownership structure of Petros Pharmaceuticals (PTPI) stock is a mix of institutional, retail, and individual investors. Approximately 1.79% of the company’s stock is owned by Institutional Investors, and 98.21% is owned by Public Companies and Individual Investors.
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 44,386 | Institution | 0.44% | 13,316 | |
| 31,811 | Institution | 0.32% | 9,543 | |
| 31,811 | Institution | 0.32% | 9,543 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 44,386 | Institution | 0.44% | 13,316 | |
| 31,811 | Institution | 0.32% | 9,543 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 31,811 | Institution | 0.32% | 8,729 |
FAQ
Who Owns Petros Pharmaceuticals (PTPI)?
Currently, no data Available
What percentage of Petros Pharmaceuticals (PTPI) stock is held by institutional investors?
According to the latest TipRanks data, approximately 0.71% of Petros Pharmaceuticals (PTPI) stock is held by institutional investors.
What percentage of Petros Pharmaceuticals (PTPI) stock is held by retail investors?
According to the latest TipRanks data, approximately 98.21% of Petros Pharmaceuticals (PTPI) stock is held by retail investors.
Who owns the most shares of Petros Pharmaceuticals (PTPI)?
Fidelity Concord Street Trust owns the most shares of Petros Pharmaceuticals (PTPI).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.